000048046 000__ 01097nam\a2200397\i\4500
000048046 001__ 48046
000048046 003__ SzGeWIPO
000048046 005__ 20240708150357.0
000048046 006__ m\\\\eo\\d\\\\\\\\
000048046 007__ cr bn |||m|||a
000048046 008__ 230328s2023\\\\enk\\\\\o\\\\\000\0\eng\d
000048046 0247_ $$a10.1093/jiplp/jpad006$$2doi
000048046 035__ $$a(OCoLC)1373642665
000048046 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000048046 041__ $$aeng
000048046 24504 $$aChina National Intellectual Property Administration clarifies administrative adjudication measures for significant patent infringement disputes in pharmaceutical cases /
000048046 264_1 $$a[Oxford, England] :$$bOxford University Press (OUP),$$c2023
000048046 300__ $$a1 online resource (pages 77-79)
000048046 336__ $$atext$$2rdacontent
000048046 337__ $$acomputer$$2rdamedia
000048046 338__ $$aonline resource$$bcr$$2rdacarrier
000048046 4901_ $$aJournal Of Intellectual Property Law & Practice,$$x1747-1540 ;$$v18, 2, 2023
000048046 542__ $$fhttps://academic.oup.com/jiplp/article-abstract/18/2/77/7008979
000048046 588__ $$aCrossref
000048046 590__ $$aPublished online: 30-Jan-23
000048046 650_0 $$aIntellectual property.
000048046 650_0 $$aPatent Law.
000048046 650_0 $$aPharmaceuticals.
000048046 7001_ $$aYu, Qiang,$$eauthor.
000048046 7731_ $$tJournal of Intellectual Property Law & Practice$$wjiplp
000048046 830_0 $$aJournal Of Intellectual Property Law & Practice ;$$v18, 2, 2023.
000048046 85641 $$uhttps://doi.org/10.1093/jiplp/jpad006$$yOnline version
000048046 904__ $$aJournal article
000048046 980__ $$aJIPLP